{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:33:31Z","timestamp":1791282811851,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Sanming Project of Medicine in Shenzhen","award":["SZSM201812002"],"award-info":[{"award-number":["SZSM201812002"]}]},{"name":"the Shenzhen Key Medical Discipline Construction Fund","award":["SZGSP012"],"award-info":[{"award-number":["SZGSP012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for nonspecific symptoms, laboratory or imaging findings. In this study, we aimed to describe the clinical manifestations of patients with KFD and to access the potential role of serum cytokines in the diagnosis of this disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with KFD were retrospectively enrolled from January 2015 to November 2021 at Shenzhen Children\u2019s Hospital. Clinical data were collected from inpatient or outpatient medical records. Serum cytokines were detected by the Flowcytomix technique. Serum levels of cytokines were compared between patients with KFD and SJIA, or patients with KFD and KD. The data of patients without MAS were further analyzed. A receiver operating characteristic (ROC) curve analysis was further performed to access the potential role of serum cytokines in the diagnosis of KFD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum cytokines were detected in 25 (43.8%, 25\/57) patients with a histological diagnosis of KFD. Compared to SJIA or KD patients, the KFD group had a significantly higher IFN-\u03b3\/IL-6 ratio and much lower levels of serum IL-6. The median level of serum IFN-\u03b3 in KFD was 41.65\u00a0pg\/ml (range, 21.04\u201370.74\u00a0pg\/ml), which was much higher than that in SJIA (median: 3.33\u00a0pg\/ml, <jats:italic>p<\/jats:italic>\u2009=\u20090.16) or KD (median: 2.6\u00a0pg\/ml, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). After excluding patients with MAS, there was statistical significance in all comparisons of serum IFN-\u03b3, IFN-\u03b3\/IL-6 ratio, and serum IL-6. The cutoff values of serum IFN-\u03b3, IL-6, and IFN-\u03b3\/IL-6 ratio for differentiating KFD from SJIA were\u2009&gt;\u20098.48\u00a0pg\/ml,\u2009&lt;\u200947.42\u00a0pg\/ml, and\u2009&gt;\u20090.45, respectively. The cutoff values of serum IFN-\u03b3, IL-6, and IFN-\u03b3\/IL-6 ratio for differentiating KFD from KD were\u2009&gt;\u20098.56\u00a0pg\/ml,\u2009&lt;\u200950.45\u00a0pg\/ml, and\u2009&gt;\u20090.45, respectively. The specificity of all those cutoff values for differentiating KFD from SJIA or KD was\u2009\u2265\u200994.7%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For patients with fever of unknown etiology and lymphadenopathy, after excluding HLH or MAS, serum IFN-\u03b3\u2009&gt;\u20098.56\u00a0pg\/mL and IFN-\u03b3\/IL-6 ratio\u2009&gt;\u20090.45 may highly suggest the diagnosis of KFD; serum IL-6\u2009&gt;\u200950.45\u00a0pg\/mL indicates that the probability of KFD may be small, and sJIA, KD, and acute infection should be excluded first.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00877-w","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T16:04:00Z","timestamp":1692720240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated serum IFN-\u03b3and IFN-\u03b3\/IL-6 ratio in Kikuchi-Fujimoto disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Tingyan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"10","key":"877_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/ijd.13314","volume":"55","author":"LM Mathew","year":"2016","unstructured":"Mathew LM, Kapila R, Schwartz RA. Kikuchi-Fujimoto disease: a diagnostic dilemma. Int J Dermatol. 2016;55(10):1069\u201375.","journal-title":"Int J Dermatol"},{"issue":"11","key":"877_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.5858\/arpa.2018-0219-RA","volume":"142","author":"AM Perry","year":"2018","unstructured":"Perry AM, Choi SM. Kikuchi-Fujimoto disease: a review. Arch Pathol Lab Med. 2018;142(11):1341\u20136.","journal-title":"Arch Pathol Lab Med"},{"key":"877_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jpeds.2020.08.063","volume":"229","author":"Y Yang","year":"2021","unstructured":"Yang Y, Lian H, Ma H, Zhao Y, Zhang Q, Zhang L, et al. Hemophagocytic lymphohistiocytosis associated with histiocytic necrotizing lymphadenitis: a clinical study of 13 children and literature review. J Pediatr. 2021;229:267-274.e3.","journal-title":"J Pediatr"},{"issue":"7","key":"877_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00247-008-0894-x","volume":"38","author":"GY Lim","year":"2008","unstructured":"Lim GY, Cho B, Chung NG. Hemophagocytic lymphohistiocytosis preceded by Kikuchi disease in children. Pediatr Radiol. 2008;38(7):756\u201361.","journal-title":"Pediatr Radiol"},{"issue":"12","key":"877_CR5","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1007\/s10067-021-05769-6","volume":"40","author":"B Rai","year":"2021","unstructured":"Rai B, Pillinger MH, Panush RS. Coincident Kikuchi-Fujimoto\u2019s disease and adult-onset Still\u2019s disease: report of a patient from an uncommonly affected population and case-directed systematic review. Clin Rheumatol. 2021;40(12):4791\u2013805.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"877_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/jcp.2004.018010","volume":"57","author":"YK Jeon","year":"2004","unstructured":"Jeon YK, Paik JH, Park SS, Park SO, Kim YA, Kim JE, et al. Spectrum of lymph node pathology in adult onset Still\u2019s disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol. 2004;57(10):1052\u20136.","journal-title":"J Clin Pathol"},{"issue":"5","key":"877_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/10428190290021641a","volume":"43","author":"K Ohshima","year":"2002","unstructured":"Ohshima K, Haraoka S, Takahata Y, Takada H, Tsutiya K, Suzuk K, et al. Interferon-gamma, interleukin-18, monokine induced by interferon-gamma and interferon-gamma-inducible protein-10 in histiocytic necrotizing lymphadenitis. Leuk Lymphoma. 2002;43(5):1115\u201320.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"877_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2141.1996.d01-1964.x","volume":"95","author":"M Kubota","year":"1996","unstructured":"Kubota M, Tsukamoto R, Kurokawa K, Imai T, Furusho K. Elevated serum interferon gamma and interleukin-6 in patients with necrotizing lymphadenitis (Kikuchi\u2019s disease). Br J Haematol. 1996;95(4):613\u20135.","journal-title":"Br J Haematol"},{"issue":"1","key":"877_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/mr\/roab115","volume":"33","author":"O Koker","year":"2023","unstructured":"Koker O, Demirkan FG, Cakmak F, Aktay AN. Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: a single-centre experience. Mod Rheumatol. 2023;33(1):187\u201393.","journal-title":"Mod Rheumatol"},{"issue":"11","key":"877_CR10","first-page":"2544","volume":"28","author":"M Krumrey-Langkammerer","year":"2001","unstructured":"Krumrey-Langkammerer M, Hafner R. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol. 2001;28(11):2544\u20137.","journal-title":"J Rheumatol"},{"issue":"17","key":"877_CR11","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"3","key":"877_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic Juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016;75(3):481\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"877_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-023-00788-w","volume":"21","author":"Z Shen","year":"2023","unstructured":"Shen Z, Ling J, Zhu X, Yang J, He T. Macrophage activation syndrome in children with Kikuchi-Fujimoto disease. Pediatr Rheumatol Online J. 2023;21(1):10.","journal-title":"Pediatr Rheumatol Online J"},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpeds.2015.12.064","volume":"171","author":"HM Kang","year":"2016","unstructured":"Kang HM, Kim JY, Choi EH, Lee HJ, Yun KW, Lee H. Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. J Pediatr. 2016;171:208-12.e1.","journal-title":"J Pediatr"},{"key":"877_CR15","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, et al. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"877_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","volume":"17","author":"F De Benedetti","year":"2021","unstructured":"De Benedetti F, Prencipe G, Bracaglia C, Marasco E, Grom AA. Targeting interferon-gamma in hyperinflammation: opportunities and challenges. Nat Rev Rheumatol. 2021;17(11):678\u201391.","journal-title":"Nat Rev Rheumatol"},{"key":"877_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41\u2013101.","journal-title":"Adv Immunol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00877-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:29:44Z","timestamp":1700238584000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00877-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00877-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participating members were enrolled with the approval of the ethics committee of Shenzhen Children\u2019s Hospital and provided written consent from legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of this anonymous information was obtained from patients\u2019 legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}